<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02497144</url>
  </required_header>
  <id_info>
    <org_study_id>Gazi University3</org_study_id>
    <nct_id>NCT02497144</nct_id>
  </id_info>
  <brief_title>Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease</brief_title>
  <official_title>Effects of Neuromuscular Electrical Stimulation on Functional Exercise Capacity and Quality of Life in Patients With Interstitial Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Decreased exercise capacity and quality of life, increased dyspnea and fatigue perception and
      hypoxemia during exercise is seen in patients with interstitial lung disease. Impaired
      ventilatory response, increased lung compliance, ventilation-perfusion mismatching and
      inadequate peripheral circulation causes decreased exercise capacity. Another important
      factor that induce decreased exercise capacity is peripheral muscle weakness. In literature,
      there is no study investigated effects of neuromuscular electrical stimulation on functional
      exercise capacity, respiratory and peripheral muscle strength, pulmonary functions, physical
      activity level, dyspnea and fatigue perception in patients with interstitial lung disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In literature, there was increased quantity of study investigated effects of neuromuscular
      electrical stimulation in chronic lung disease patients. It was used as a pulmonary
      rehabilitation component especially in patients with decreased exercise capacity and
      peripheral muscle strength, intensely increased dyspnea inhibits exercise. It was
      demonstrated that neuromuscular electrical stimulation improved functional exercise capacity,
      peripheral muscle strength and quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional exercise capacity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Six minute walk test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary functions</measure>
    <time_frame>6 weeks</time_frame>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory and expiratory muscle strength (MIP,MEP)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Mouth pressure device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>6 weeks</time_frame>
    <description>Modified Borg and Modified Medical Research Council (MMRC) Dyspnea scales</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral muscle strength</measure>
    <time_frame>6 weeks</time_frame>
    <description>Hand held dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal exercise capacity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Incremental shuttle walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>6 weeks</time_frame>
    <description>Fatigue Severity Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Metabolic holter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 weeks</time_frame>
    <description>Leicester Cough Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>6 weeks</time_frame>
    <description>Montgomery Asberg Depression Rating Scale (MADRS) (Turkish versions of all scales)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 weeks</time_frame>
    <description>Short Form (SF-36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 weeks</time_frame>
    <description>Saint George Quality of Life Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Interstitial Lung Disease</condition>
  <arm_group>
    <arm_group_label>NMES Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: NMES group will receive neuromuscular electrical stimulation using high frequency galvanic stimulation and breathing exercises.
Neuromuscular electrical stimulation will be applied bilaterally to quadriceps femoris muscle for 3days/6 weeks by a physiotherapist.
NMES group will also perform breathing exercises 120 times/day, 7 days/week, for 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham: Control group will receive breathing exercises. Control group will perform breathing exercises 120 times/day, 7 days/week, for 6 weeks.
Control group will be followed-up by telephone once a week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NMES Group</intervention_name>
    <description>Neuromuscular electrical stimulation</description>
    <arm_group_label>NMES Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>Breathing exercises</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with interstitial lung disease

          -  Clinically stable

          -  Under standard medication

          -  Having no exacerbation or infection

        Exclusion Criteria:

          -  Cognitive disorders

          -  Orthopedic and neurological problems

          -  Contraindications to apply the neuromuscular electrical stimulation (pace maker,
             sensory defects, etc...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meral Boşnak-Güçlü, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Burcu Camcıoğlu, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Müşerrefe N Karadallı, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Deran Oskay, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Haluk Türktaş, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meral Boşnak-Güçlü, PhD</last_name>
    <phone>+903122162600</phone>
    <phone_ext>62929</phone_ext>
    <email>bosnakmeral@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Burcu Camcıoğlu, MSc</last_name>
    <phone>+903122162600</phone>
    <phone_ext>62929</phone_ext>
    <email>burcu.camcioglu@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <zip>06500</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meral Boşnak-Güçlü, PhD</last_name>
      <phone>+903122162600</phone>
      <phone_ext>62929</phone_ext>
      <email>bosnakmeral@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Burcu Camcıoğlu, MSc</last_name>
      <phone>+903122162600</phone>
      <phone_ext>62929</phone_ext>
      <email>burcu.camcioglu@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest. 2005 Jan;127(1):284-94. Review.</citation>
    <PMID>15653996</PMID>
  </results_reference>
  <results_reference>
    <citation>Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP 3rd, Martinez FJ. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1084-90. Epub 2003 Aug 13.</citation>
    <PMID>12917227</PMID>
  </results_reference>
  <results_reference>
    <citation>Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, Demedts MG, Decramer M. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax. 2005 Jan;60(1):32-8.</citation>
    <PMID>15618580</PMID>
  </results_reference>
  <results_reference>
    <citation>Vivodtzev I, Lacasse Y, Maltais F. Neuromuscular electrical stimulation of the lower limbs in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2008 Mar-Apr;28(2):79-91. doi: 10.1097/01.HCR.0000314201.02053.a3. Review.</citation>
    <PMID>18360183</PMID>
  </results_reference>
  <results_reference>
    <citation>Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax. 2002 Dec;57(12):1045-9.</citation>
    <PMID>12454299</PMID>
  </results_reference>
  <results_reference>
    <citation>Sillen MJH, Speksnijder CM, Eterman RA, Janssen PP, Wagers SS, Wouters EFM, Uszko-Lencer NHMK, Spruit MA. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature. Chest. 2009 Jul;136(1):44-61. doi: 10.1378/chest.08-2481. Epub 2009 Apr 10. Review.</citation>
    <PMID>19363213</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>July 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2015</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Meral Boşnak Güçlü</investigator_full_name>
    <investigator_title>Assoc. Prof</investigator_title>
  </responsible_party>
  <keyword>interstitial lung disease</keyword>
  <keyword>neuromuscular electrical stimulation</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

